ASU Help Center question mark icon

George.Poste@asu.edu

Chf Scientist & Regent's Prof
CASI
Administrative Staff
Mail Code: 9908

1475 N. Scottsdale Rd. SkySong - Suite 361F (Map)
(480)727-8662

Bio

Curriculum Vitae

Dr. George Poste is Chief Scientist, Complex Adaptive Systems Initiative (CASI) (http://www.casi.asu.edu/), Regents’ Professor and Del E. Webb Chair in Health Innovation at Arizona State University. He assumed this post in February 2009. This program links expertise across the university in research on synthetic biology, ubiquitous sensing and healthcare informatics for personalized medicine. 

He founded the Biodesign Institute at ASU (www.biodesign.asu.edu/) and served as Director for 2003 to 2009. In creating this Institute, Dr. Poste designed and built 400,000 sq. ft. of new facilities, achieved cumulative research funding of $300 million and recruited over 60 faculty, including three members of the National Academies of Science and Engineering.
 
He serves on the Board of Directors of Monsanto (since 2003), Exelixis (since 2004), Caris Life Sciences (since 2005), and the Scientific Advisory Board of Synthetic Genomics (since 2009).  From 1992 to 1999 he was Chief Science and Technology Officer and President, R&D of SmithKline Beecham (SB).  During his tenure at SB he was associated with the successful registration of 31 drug, vaccine and diagnostic products.  In 2004 he was named as ‘R&D Scientist of the Year’ by R&D Magazine, in 2006 he received the Einstein award from the Global Business Leadership Council and in 2009 received the Scrip Lifetime Achievement award voted by the leadership of the global pharmaceutical industry.

He has published over 350 research papers and edited 14 books on pharmaceutical technologies and oncology. He has received honorary degrees in science, law and medicine for his research contributions and was honored in 1999 by HM Queen Elizabeth II as a Commander of the British Empire for his contributions to international healthcare and security.

He is a Fellow of the Royal Society, the Royal College of Pathologists and the UK Academy of Medicine, a Distinguished Fellow at the Hoover Institution, Stanford University and a member of the Council for Foreign Relations.  He served as a member of the Defense Science Board from 2003 to 2009 and Health Board of the US Department of Defense (DoD) and is currently a member of the US Institute of Medicine Board on Global Health.  He has served as a member of Advisory Committees for multiple U.S. Government Agencies in areas of defense, national security and healthcare.

Publications and Other Intellectual ContributionsGoogle Scholar

  1. Claudia Acquisti, George Poste, David Curtiss, Sudhir Kumar. Nullomers: really a matter of natural selection?. PLoS ONE (2007).

  2. Poste, George Henry. Issues in Bioterrorism and Defense: A View of the Future in Technology Futures and Global Power, Wealth and Conflict. CSIS (2006).

  3. P Hotez, R Gupta, R Mahoney, George Poste. Incorporating appropriate technology into North American schools of public health. Pan Am J Public Health (2005).

  4. George Poste. Statement on Scientific Publication and Security. Nature (2003).

  5. Poste, George. Genes and Molecular Medicine. Cambridge (2003).

  6. George Poste. Biotechnology, Bioterrorism and Biosecurity. Drug Discovery World (2002).

  7. George Poste. Facing Reality in Preparing for Biological Warfare. Health Affairs (2002).

  8. George Poste. Molecular diagnostics: a powerful new component of the healthcare value chain. Expert Rev. Mol. Diag (2001).

  9. George Poste. Biotechnology and the Evolution of Molecular Medicine. J. Biolaw and Bus Supplement (2000).

  10. R Fears, D Roberts, George Poste. Rational or rationed medicine? The promise of genetics for improved clinical practice. BMJ (2000).

  11. Hirst, Damient, Burn, Gordon, Poste, George Henry. Revealing Reality Within a Body of Imaginary Things. Essays for Theories, Models, Methods, Approaches, Assumptions and Findings. Gagosian Gallery (2000).

Your profile? Go to FAR to control which information is displayed.

Presentations

  1. Poste, George Biological Threats: New Military Capabilities and Strategic Challenges for National Security. St. Michaels Forum III, US Intelligence Science Board. (Oct 2005).
  2. Poste, George The Increasing Importance of the Life Sciences in Defense Technologies and National Security. Cordia Symposium. (Oct 2005).
  3. Poste, George Challenges in the Commercial Development of New Drugs and Vaccines. University of Texas Medical Branch Symposium: Facing the Future. Biodefense and Emerging Infectious Diseases. (Aug 2005).
  4. Poste, George Countermeasures and Responses to Bioterrror and Emerging Infectious Diseases. (Jun 2005).
  5. Poste, George The Increasing Importance of the Life Sciences in Defense Technologies and National Security. Fubini Lecture, Lincoln Laboratories, MIT. (Jun 2005).
  6. Poste, George Bugs Damn Bugs! Where we are Now in the Fight Against Superbugs. Sophie Meeting. (Jun 2005).
  7. Poste, George Biotechnology and Computing: The Principal Drivers of Change in Healthcare. Transforming American Healthcare Symposium. (Apr 2005).
  8. Poste, George Biotechnology, Bioterrorism and Biosecurity. Symposium on Global Challenges. (Apr 2005).
  9. Poste, George Global Urbanization: Environment, Epidemics and Emerging Infectious Diseases. Keynote address at Landscape Architecture Foundation Symposium, Remaking Metropolis: Global Environmental Challenges to the Urban Landscape. (Apr 2005).
  10. Poste, George The Imperative for Curriculum Reform in Medical Education in the Early 21st Century. Gubernatorial Commission on Medical Education. (Mar 2005).
  11. Poste, George Preparedness for Bioterrorism and other Mass Casualty Incidents. Keynote Address, Second Annual World Security Conference. (Feb 2005).
  12. Poste, George The Strategic Environment for Pharmaceutical and Biotechnology Companies. Healthcare Executive Leadership Forum. (Dec 2004).
  13. Poste, George The Urgent Imperative for Innovative R&D Programs to Control the Growing Threat from Infectious Diseases. (Oct 2004).
  14. Poste, George Biotechnology, Bioterrorism and Biosecurity. Bioterrorism Session with Mayor Bloomberg. (Oct 2004).
  15. Poste, George Personalized Medicine. (Sep 2004).
  16. Poste, George Policy, Pricing and Regulatory Issues in the Pharmaceutical Industry. Atlas Ventures Life Sciences Meeting. (Sep 2004).
  17. Poste, George The Strategic Environment of Innovation in Healthcare: Evolving New Business Models for Pharmaceutical and Biotechnology Companies. Keynote Address, Global Pharma R&D Summit. (Sep 2004).
  18. Poste, George Trends in Biotechnology Implications for Defense Policy and National Security. CSIS Symposium on Technology Frontiers. (Jun 2004).
  19. Poste, George Synthetic Biology: Charting Rational Public Policies for the Oversight and Regulation of Vanguard Technologies. (Jun 2004).
  20. Poste, George Risk, Reward and Regulation: Charting Rational Public Policies for Vanguard Technologies. Keynote Address: The International Biotechnology Summit. (May 2004).
  21. Poste, George Surviving in a Hazardous World: Risk, Response, Regulation and Responsibility. Keynote Address, Health Protection Agency Anniversary Dinner. (Apr 2004).
  22. Poste, George Molecular Medicine: Computing and the Evolution of Healthcare. BioIT Conference. (Mar 2004).
  23. Poste, George Genetics and Computing: The Evolution of Molecular Medicine and e.health. HIMSS Conference. (Feb 2004).
  24. Poste, George The Past, Present and Future of Pharmacogenomics in Clinical R&D. Keynote address, Life Sciences Pharamcogenomics Conference. (Feb 2004).
  25. Poste, George The Biotechnology Sector: Aspirations and Adaptability in Challenging Times. Keynote Address, AdvancePCS Annual Healthcare Conference. (Jan 2004).
  26. Poste, George Comprehending Complex Biological Systems: Harnessing Nature's Designs for Innovations in Healthcare, Engineering and Security. CSBI Symposium. (Jan 2004).
  27. Poste, George A Look at R&D: Priming the Pump or A Well Run Dry?. (Dec 2003).
  28. Poste, George Systems Biology: The Convergence of Biology, Engineering and Computing. Department of Trade and Industry Symposium. (Nov 2003).
  29. Poste, George The Competitive Challenge in Biotechnology. (Nov 2003).
  30. Poste, George The Challenge of Translational Research. Biofunding Summit 2003. (Oct 2003).
  31. Poste, George Genetics, Informatics and the Evolution of Molecular Medicine. Keynote Address, Scientific American Biosilico. (Oct 2003).
  32. Poste, George Defining the Pharmaceutical R&D Problem and Prescription for Remedy. Windover Pharmaceutical Strategic Alliances Conference: Deal Making for Pragmatic Times. (Sep 2003).
  33. Poste, George Value Creation in Biotechnology. 2003 Atlas Ventures Life Sciences CEO Forum. (Sep 2003).
  34. Poste, George Biotechnology, Bioterrorism and Biosecurity. 2003 Dorsey Hughes Symposium. (Jul 2003).
  35. Poste, George Biotechnology, Bioterrorism and Biosecurity. MPM Capital Annual Healthcare Conference. (Jun 2003).
  36. Poste, George Policy Formulation in Addressing the Global Challenge of Biosecurity. Joint Symposium: International Institute for Strategic Studies, Chemical and Biological Arms Control Institute and Institute of Medicine, Forum on Emerging Infections. (Jun 2003).
  37. Poste, George The Productivity and Paradox in Pharmaceutical R&D. The Biopharmaceutical Conference in Europe. (Jun 2003).
  38. Poste, George The Path Towards Personalized Medicine. Amersham Lecture. (Apr 2003).
  39. Poste, George Genes and Molecular Medicine. The Golden Double Helix: 50 Years of DNA Conference. (Apr 2003).
  40. Poste, George Optimizing R&D Strategies and Productivity in the Pharmaceutical and Biotechnology Indsutries: Adaptive Incremental Change? Or Radical Revision?. R&D Leaders Forum. (Apr 2003).

Your profile? You control what’s displayed. Customize your information.

Research Activity Research Awards

  1. Poste,George Henry * , Johnston,Stephen Albert , Lindsay,Stuart , Lindsay,Stuart , Stafford,Phillip , Woodbury,Neal Walter , Yan,Hao , Zhao,Zhan-Gong , . INSPIRE: Mimicking the Functional Complexity of Biology with Man-Made Systems. NSF-BIO (7/15/2012 - 6/30/2015).
  2. Johnston,Stephen Albert * , Papandreou-Suppappola,Antonia , Poste,George Henry , Stafford,Phillip , Woodbury,Neal Walter , Poste,George Henry * , Johnston,Stephen Albert , Stafford,Phillip , Sykes,Kathryn , . Detection of changes in health status and source of any infection using peptide array chips Technical PI: Stephen Johnston. DOD-DTRA (4/24/2012 - 12/31/2013).
  3. Poste,George Henry * . Innovation Demands Boldness: A New Workshop Series to Build the Strategic Competitiveness of Research in Arizona: Workshop #1-Disrupti (see comments). SFAz (3/1/2010 - 2/28/2011).
  4. Hartwell,Leland Harrison * Birt,Michael Nelson,Alan C Poste,George Henry . Virginia G Piper Center for Personalized Diagnostics. ASU FDN (12/7/2007 - 6/30/2013).
  5. Guston,David H * , Bennett,Ira Mccoy , Boradkar,Prasad , Boradkar,Prasad , Boradkar,Prasad , Carlson,Marilyn P , Conz,David B , Corley,Elizabeth , Corley,Kevin Gene , Fisher,Erik , Hackett,Edward John , Meldrum,Deirdre Ruth , Miller,Clark Anson , Monahan,Torin Michael , Nelson,Alan C , Poste,George Henry , Robert,Jason , Sarewitz,Daniel , Sarewitz,Daniel , Sarewitz,Daniel , Sarewitz,Daniel , Schneider,Anne L , Selin,Cynthia Lea , Wetmore,Jameson Michael , . NSEC: Center for Nanotechnology in Society at Arizona State University. NSF-SBE (9/21/2007 - 3/31/2012).
  6. Poste,George Henry * , Johnson,William G , Matt,Kathleen Sharon , Melnyk,Bernadette Mazurek , Panchanathan,Sethuraman , Zenhausern,Frederic , Zenhausern,Frederic , . Arizona Clinical and Translational Science Award. TGen (9/22/2006 - 9/21/2007).
  7. Poste,George Henry * . Development of Intelligence Community-Industry Linkages for Improved Risk Identification and Mitigation. DOD-ARMY-CSS (8/10/2006 - 8/29/2007).
  8. Guston,David H * , Boradkar,Prasad , Carlson,Marilyn P , Corley,Elizabeth , Corley,Elizabeth , Hackett,Edward John , Monahan,Torin Michael , Poste,George Henry , Robert,Jason , Sarewitz,Daniel , Sarewitz,Daniel , Schneider,Anne L , . NSEC: Center for Nanotechnology in Society at Arizona State University. NSF-SBE (10/1/2005 - 3/31/2012).

* principal investigator

Your profile? You control what’s displayed. Customize your information.

Service

  1. Sloan Foundation Expert Advisory Group on Influenza Pandemic Preparedness, Member (2009 - present)
  2. Synthetic Genomics, Scientific Advisory Board (2009 - present)
  3. Editorial Board, Bioterrorism and Biosecurity, Member (2008 - present)
  4. Caris Life Sciences, Vice Chairman (2005 - present)
  5. Burrill and Company, Advisory Board (2004 - present)
  6. Exelixis, Board Member (2004 - present)
  7. Exelixis, Board Member (2004 - present)
  8. Monsanto, Board Member (2003 - present)
  9. The Institute of Medicine of The National Academies, Forum on Microbial Threats, Member (2003 - present)
  10. Orchid Biosciences, Chairman (2002 - present)
  11. Defense Health Board, US Department of Defense, Member (2008 - 2009)
  12. Defense Science Board, US Department of Defense, Member (2003 - 2009)
  13. Orchid Biosciences, Chairman (2002 - 2009)
  14. Sloan Foundation Task Force on Synthetic Biology, Member (2008)
  15. The Institute of Medicine of The National Academies, Committee Member (2006)
  16. Institute of Medicine of The National Academies, Committee Member (2005 - 2006)
  17. Institute of Medicine: National Research Council, US National Academy of Sciences, Member (2005 - 2006)
  18. The Institute of Medicine of The National Academies, Committee Member (2005)
  19. Threat Reduction Advisory Committee, United States Department of Defense, Member (2001 - 2005)
  20. AdvancePCS, Board Member (2002 - 2003)
  21. Board of Trustees; The International Vaccine Institute, Seoul, Korea, Member (2000 - 2003)
  22. Illumina, Board Member (2000 - 2003)
  23. diaDexus, Chairman (1997 - 2003)
  24. Governing Board, Beckman Center for Molecular and Genetic Medicine, Stanford University, Member (1993 - 2003)
  25. Advisory Committee on International Economic Policy, United States State Department, Member
  26. Biological Weapons Working Group, National Academy of Sciences, Member
  27. Board of Trustees; The International Vaccine Institute, Seoul, Korea, Member
  28. Board on Global Health, National Academy of Sciences Institute of Medicine, Member
  29. Committee on Advances in Technology and Next Generation Biowarfare Threats. Institute of Medicine: National Research Council, US National Academy of Sciences, Member
  30. Defense Science Board, United States Department of Defense, member
  31. Editorial Board, Bioterrorism and Biosecurity, Member
  32. Editorial Board, Current Opinion in Biotechnology, Member
  33. Editorial Board, Expert Opinion on Investigational Drugs, Member
  34. Editorial Board, Expert Opinion on Molecular Diagnostics, Member
  35. Editorial Board, Journal of Commercial Biotechnology, Member
  36. Editorial Board, Nature Bio/Technology, Member
  37. Editorial Board, Pharmacogenomics, Member
  38. Editorial Board, Polymers in Medicine and Biotechnology, Member
  39. Editorial Board, The Journal of Biolaw and Business, Member
  40. Senior Advisory Panel, Current Drugs, Member

Your profile? You control what’s displayed. Customize your information.

Curriculum Vitae / Resume

  1. Download (this file has not been virus scanned)

Your profile? You control what’s displayed. Customize your information.